Senior insider sale
Chief Executive Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$149.7K
32.63K shares
What this filing means
TOWNSEND RICHARD NOLAN plans to sell 32.63K shares of LEXEO THERAPEUTICS, INC. valued at approximately $149.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001959173-26-006154
DirectorOfficer· Chief Executive Officer
Since Feb 2026
32.63K
Shares to sell
$149.7K
Approx. market value
3.35K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
8/17/2026
3.35KTotal acquired3.35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Restricted Stock Vesting Compensation | 3.35K | — |
| Total | 3.35K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
25.95K
Market value
$116.2K
7/1/2026
—Completed
Units to sell
3.34K
Market value
$16.9K
5/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.35K
Market value
$16.6K
8/18/2026
Total
Units
32.63K
Value
$149.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 25.95K | $116.2K | — | Completed |
5/18/2026 | 3.34K | $16.9K | — | Completed |
| Planned — Approximate Date | ||||
8/18/2026 | 3.35K | $16.6K | NASDAQ | Planned |
| Total | 32.63K | $149.7K | ||